Found: 8
Select item for more details and to access through your institution.
Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101).
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 4, p. 1596, doi. 10.3390/jcm12041596
- By:
- Publication type:
- Article
Siliceous Sandstones Used in Local Khmer Temples in Battambang, Ta Keo, and Kampong Cham Provinces, Cambodia.
- Published in:
- Heritage (2571-9408), 2024, v. 7, n. 2, p. 608, doi. 10.3390/heritage7020029
- By:
- Publication type:
- Article
Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer.
- Published in:
- Acta Oncologica, 2012, v. 51, n. 7, p. 867, doi. 10.3109/0284186X.2012.682629
- By:
- Publication type:
- Article
Multicenter Cohort Study to Assess the Association between Changes on Imaging and Outcome after Regorafenib Treatment (KSCC1603).
- Published in:
- Oncology, 2020, v. 98, n. 10, p. 719, doi. 10.1159/000507814
- By:
- Publication type:
- Article
A Phase I Trial of Oxaliplatin, Irinotecan, and S‐1 Combination Therapy (OX‐IRIS) as Chemotherapy for Unresectable Pancreatic Cancer (HGCSG 1403).
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1675, doi. 10.1002/onco.13838
- By:
- Publication type:
- Article
Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors.
- Published in:
- Oncologist, 2016, v. 21, n. 12, p. 1483, doi. 10.1634/theoncologist.2016-0051
- By:
- Publication type:
- Article
Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1567, doi. 10.1111/cas.14841
- By:
- Publication type:
- Article